S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer::https://clinicaltrials.gov/ct2/show/NCT01674140?term=d+i+a+b+e+t+e+s&amp;rank=12

Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indstria e Comrcio Ltda. Compared to Granulokine Produced by Produtos Roche Qumicos e Farmacuticos S/A.::https://clinicaltrials.gov/ct2/show/NCT01549301?term=d+i+a+b+e+t+e+s&amp;rank=6

Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma::https://clinicaltrials.gov/ct2/show/NCT01979536?term=d+i+a+b+e+t+e+s&amp;rank=14

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects::https://clinicaltrials.gov/ct2/show/NCT01975389?term=d+i+a+b+e+t+e+s&amp;rank=20

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma::https://clinicaltrials.gov/ct2/show/NCT01190930?term=d+i+a+b+e+t+e+s&amp;rank=11

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma::https://clinicaltrials.gov/ct2/show/NCT02048813?term=d+i+a+b+e+t+e+s&amp;rank=15

A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera::https://clinicaltrials.gov/ct2/show/NCT01901432?term=d+i+a+b+e+t+e+s&amp;rank=7

Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D::https://clinicaltrials.gov/ct2/show/NCT01534234?term=d+i+a+b+e+t+e+s&amp;rank=18

Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia::https://clinicaltrials.gov/ct2/show/NCT00720109?term=d+i+a+b+e+t+e+s&amp;rank=8

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma::https://clinicaltrials.gov/ct2/show/NCT00408005?term=d+i+a+b+e+t+e+s&amp;rank=1

S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer::https://clinicaltrials.gov/ct2/show/NCT02164916?term=d+i+a+b+e+t+e+s&amp;rank=16

A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects::https://clinicaltrials.gov/ct2/show/NCT01720537?term=d+i+a+b+e+t+e+s&amp;rank=13

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia::https://clinicaltrials.gov/ct2/show/NCT02085408?term=d+i+a+b+e+t+e+s&amp;rank=10

Lung-MAP: S1400 Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IIIB-IV Squamous Cell Lung Cancer::https://clinicaltrials.gov/ct2/show/NCT02154490?term=d+i+a+b+e+t+e+s&amp;rank=2

A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa::https://clinicaltrials.gov/ct2/show/NCT00134966?term=d+i+a+b+e+t+e+s&amp;rank=19

A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer::https://clinicaltrials.gov/ct2/show/NCT02370238?term=d+i+a+b+e+t+e+s&amp;rank=9

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia::https://clinicaltrials.gov/ct2/show/NCT01371981?term=d+i+a+b+e+t+e+s&amp;rank=3

Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera::https://clinicaltrials.gov/ct2/show/NCT00928707?term=d+i+a+b+e+t+e+s&amp;rank=17

An Open-Label, Dose-Escalation Study of IMC-20D7S In Patients With Malignant Melanoma::https://clinicaltrials.gov/ct2/show/NCT01137006?term=d+i+a+b+e+t+e+s&amp;rank=5

Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas::https://clinicaltrials.gov/ct2/show/NCT01897012?term=d+i+a+b+e+t+e+s&amp;rank=4